Cargando…

Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study

INTRODUCTION: Clinical trials have shown that liraglutide effectively lowers glycated hemoglobin A1c (A1C) levels in adult patients with type 2 diabetes (T2D). However, no studies have evaluated the effectiveness of liraglutide by body mass index (BMI) in the United States (US) in clinical practice....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chitnis, Abhishek S., Ganz, Michael L., Benjamin, Nicole, Langer, Jakob, Hammer, Mette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176953/ https://www.ncbi.nlm.nih.gov/pubmed/25245811 http://dx.doi.org/10.1007/s12325-014-0153-5

Ejemplares similares

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
por: Li, Qian, et al.
Publicado: (2014)

The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
por: Ganz, Michael L, et al.
Publicado: (2014)

Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study
por: Buysman, Erin K., et al.
Publicado: (2015)

Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Failing Metformin Monotherapy in the United States
por: Langer, Jakob, et al.
Publicado: (2013)

Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial
por: Lingvay, Ildiko, et al.
Publicado: (2017)

Determining whether the effect of liraglutide on non‐alcoholic fatty liver disease depends on reductions in the body mass index
por: Shiomi, Megumi, et al.
Publicado: (2020)

Diet quality of children in the United States by body mass index and sociodemographic characteristics
por: Thomson, Jessica L., et al.
Publicado: (2019)

Increasing Pre-pregnancy Body Mass Index and Pregnancy Outcomes in the United States
por: Akinyemi, Oluwasegun A, et al.
Publicado: (2022)

Body mass index across adulthood and the development of airflow obstruction and emphysema
por: Trethewey, Ruth E, et al.
Publicado: (2022)

Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status
por: Cawley, John, et al.
Publicado: (2014)

Psychosocial Correlates of Body Mass Index in the United States: Intersection of Race, Gender and Age
por: Assari, Shervin
Publicado: (2016)

Association between body mass index and hypertension subtypes in Indian and United States adults
por: Visaria, Aayush, et al.
Publicado: (2020)

Association of body mass index with health care expenditures in the United States by age and sex
por: Ward, Zachary J., et al.
Publicado: (2021)

Mental ill-health across the continuum of body mass index
por: Kelly, Shona J, et al.
Publicado: (2011)

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta‐analysis of the liraglutide phase III clinical trial programme
por: Montanya, E., et al.
Publicado: (2016)

Association between Omega-3 Index and Hyperglycemia Depending on Body Mass Index among Adults in the United States
por: Jo, Sunyoung, et al.
Publicado: (2022)

Trends in medication use by body mass index and age between 1988 and 2012 in the United States
por: Randhawa, Arshdeep K., et al.
Publicado: (2017)

Effect of liraglutide treatment on body mass index and weight parameters in children and adolescents with type 2 diabetes: Post hoc analysis of the ellipse trial
por: Bensignor, Megan O., et al.
Publicado: (2021)

Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials
por: Verma, Subodh, et al.
Publicado: (2020)

Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone
por: Sullivan, Sean D, et al.
Publicado: (2009)

Body mass index across midlife and cognitive change in late life
por: Dahl, Anna K., et al.
Publicado: (2012)

The Association between Body Mass Index and Vitamin D Supplement Use among Adults in the United States
por: Orces, Carlos
Publicado: (2019)

Hypothalamic volume is associated with body mass index
por: Brown, Stephanie S.G., et al.
Publicado: (2023)

Neuroblastoma, Body Mass Index, and Survival: A Retrospective Analysis
por: Small, Annabel G., et al.
Publicado: (2015)

Psychiatric Status across Body Mass Index in a Mediterranean Spanish Population
por: Gutiérrez-Bedmar, Mario, et al.
Publicado: (2015)

Body mass index across adult life and cognitive function in the American elderly
por: Zhou, Yun, et al.
Publicado: (2020)

Changes in Ponderal Index and Body Mass Index across Childhood and Their Associations with Fat Mass and Cardiovascular Risk Factors at Age 15
por: Howe, Laura D., et al.
Publicado: (2010)

A genome-wide association study of body mass index across early life and childhood
por: Warrington, Nicole M, et al.
Publicado: (2015)

Cost‐effectiveness of second‐line empagliflozin versus liraglutide for type 2 diabetes in the United States
por: Reifsnider, Odette S., et al.
Publicado: (2022)

QuickStats: Rate of Cesarean Delivery, by Maternal Prepregnancy Body Mass Index Category — United States, 2020
Publicado: (2021)

The relationship between the body mass index and in‐hospital mortality in patients admitted for sudden cardiac death in the United States
por: Rozen, Guy, et al.
Publicado: (2021)

Association Between Body Mass Index and Cancer Screening Adherence Among Latinas in the United States and Puerto Rico
por: Castaneda-Avila, Maira A., et al.
Publicado: (2022)

Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide
por: DeKoven, Mitch, et al.
Publicado: (2014)

Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis
por: Lorenzi, Maria, et al.
Publicado: (2016)

The Real Ideal: Misestimation of Body Mass Index
por: Aniulis, Ellie, et al.
Publicado: (2022)

Liraglutide reduces body weight by upregulation of adenylate cyclase 3
por: Li, Z, et al.
Publicado: (2017)

Correspondence Analysis to Demonstrate the Relationship Between Musculoskeletal Pain and Body Mass Index
por: Sengar, Mili, et al.
Publicado: (2023)

Association between body shape index and risk of mortality in the United States
por: Lee, Heysoo, et al.
Publicado: (2022)

Body Mass Index and Mortality
por: Yoo, Hye Jin
Publicado: (2017)

Body mass index, blood glucose, and mortality in patients with ischemic stroke in the intensive care unit: A retrospective cohort study
por: Ma, Zisheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cad4lqvh3ln40m3edf3tc7ghr3